BOSTON and SHANGHAI, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics…
FDA-approved non-invasive treatment for depression and OCD now available at Contemporary Care’s Naples clinicImage by Contemporary Care NAPLES, Fla., Oct.…
Geniant Cranial offers precision, compact footprint, and flexible patient positioning for hospitals seeking to enhance neurosurgical outcomes SAN DIEGO, Oct.…
The Company expects to reestablish and announce a new record date as soon as possibleALAMEDA, Calif., Oct. 03, 2025 (GLOBE…
Small Business Innovation Research Grant will advance a novel neuroplastogen towards IND as potential treatment for Alcohol Use Disorder (AUD).…
Strategic integration fuels Asabys' goal to build a beyond €1 billion life sciences investment platform in Europe by 2030 Asabys incorporates…
This groundbreaking program harnesses neuroplasticity by combining the clinical strengths of counseling with the brain-enhancing power of exercise, offering a…
BOSTON, Oct. 1, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized…
Released in time for World Mental Health Day, "Transformed by His Promises" equips readers with clinically informed strategies and structured…
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Today, a coalition of leaders from academia, healthcare, technology, and employee benefits announced the…